carvedilol has been researched along with amiodarone in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (6.67) | 18.2507 |
2000's | 25 (55.56) | 29.6817 |
2010's | 17 (37.78) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Keserü, GM | 1 |
Nagashima, R; Nishikawa, T; Tobita, M | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Jia, L; Sun, H | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Ang, KK; Arkin, MR; Chen, S; Doyle, PS; Engel, JC; McKerrow, JH | 1 |
Gozalbes, R; Pineda-Lucena, A | 1 |
Sen, S; Sinha, N | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Gallardo-Godoy, A; Gever, JR; Ghaemmaghami, S; Irwin, JJ; Jacobson, MP; Li, Z; Prusiner, SB; Rao, S; Renslo, AR; Silber, BM; Widjaja, K | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Krum, H; MacMahon, S; Sharpe, N; Shusterman, N | 1 |
Eichhorn, EJ; Hamdan, MH | 1 |
Aboyoun, C; Amor, R; Keogh, AM; Lund, M; Macdonald, PS; McCaffrey, D | 1 |
Bohlmann, M; Eck, U; Nägele, H; Petersen, B; Rödiger, W | 1 |
Brutsaert, D; Conraads, V; Vrints, C | 1 |
Cosín Aguilar, J; Hernándiz Martínez, A | 1 |
Nägele, H; Petersen, B; Rödiger, W; Schomburg, R | 1 |
Cleland, JG; Deedwania, PC; Khand, AU | 1 |
Nessler, J; Skrzypek, A | 1 |
Kanoupakis, EM; Manios, EG; Mavrakis, HE; Mouloudi, HK; Tzerakis, PG; Vardas, PE | 1 |
Bozhko, AA; Kanopskiĭ, SG; Staritskiĭ, AG | 1 |
Kowey, PR | 1 |
Diaz, A; Doval, H; Ferrante, D; Grancelli, H; Nul, D; Soifer, S; Varini, S; Zambrano, C | 1 |
Fukumoto, K; Kamakura, S; Kitakaze, M; Kobayashi, T; Komamura, K; Ueno, K | 1 |
Serón, D | 1 |
Champagne, J; Connolly, SJ; Dorian, P; Fain, E; Gent, M; Hohnloser, SH; Israel, CW; Roberts, R | 1 |
Cai, Y; Jia, J; Li, S; Liu, G; Liu, Y; Pan, C; Ren, J; Yu, C | 1 |
Cleland, JG; Di Lenarda, A; Komajda, M; Lukas, MA; Metra, M; Moullet, C; Poole-Wilson, PA; Remme, W; Scherhag, A; Spark, P; Swedberg, K; Torp-Pedersen, C | 1 |
Banchs, JE; Gonzalez, MD; Naccarelli, GV; Penny-Peterson, E; Samii, S; Wolbrette, DL | 1 |
Andelfinger, G; Cadrin-Tourigny, J; Fournier, A; Khairy, P | 1 |
Hanon, S; Sato, K; Schweitzer, P; Shimada, YJ | 1 |
Hayashi, T; Hosoda, K; Matsuo, M; Miyazaki, A; Sakaguchi, H; Tsuda, E | 1 |
Hashimoto, Y; Horiuchi, I; Ishida, K; Kato, Y; Nakamura, A; Taguchi, M | 1 |
Aoyama, T; Hattori, A; Kanamori, H; Kawaguchi, T; Kawasaki, M; Kubota, T; Minatoguchi, S; Nishigaki, K; Takasugi, M; Takasugi, N; Takemura, G; Ushikoshi, H; Verrier, RL | 1 |
De Buyzere, M; De Pauw, M; Duytschaever, M; Van Heuverswyn, F | 1 |
Carballido, EM; Dow, EN; Horsley-Silva, JL; Lindor, KD; Menias, CO; Smith, ML; Vargas, HE | 1 |
Nakamura, S; Sekimoto, M; Taguchi, M; Takamori, T | 1 |
Khintibidze, I; Tsetskhladze, E | 1 |
Baek, IH; Kim, MS | 1 |
7 review(s) available for carvedilol and amiodarone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Beta-blockade and amiodarone therapy: twin brothers from different parents.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Carvedilol; Chronic Disease; Drug Interactions; Heart Failure; Humans; Propanolamines; Vasodilator Agents; Ventricular Function, Left | 1998 |
[Clinical trials on heart failure].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Calcium Channel Blockers; Carbazoles; Cardiotonic Agents; Carvedilol; Clinical Trials as Topic; Death, Sudden, Cardiac; Diuretics; Enalapril; Heart Failure; Humans; Middle Aged; Multicenter Studies as Topic; Prognosis; Propanolamines; Quality of Life; Risk Factors; Time Factors; Vasodilator Agents | 2001 |
Prevention of and medical therapy for atrial arrhythmias in heart failure.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Carbazoles; Carvedilol; Drug Therapy, Combination; Electric Countershock; Heart Failure; Humans; Pacemaker, Artificial; Phenethylamines; Propanolamines; Software Design; Sulfonamides | 2002 |
[The modern view on the role of inflammatory factors in chronic heart failure and possibilities of pharmacological modification].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; C-Reactive Protein; Carbazoles; Carvedilol; Chronic Disease; Cytokines; Etanercept; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin G; Pentoxifylline; Platelet Aggregation Inhibitors; Propanolamines; Receptors, Tumor Necrosis Factor; Vasodilator Agents | 2003 |
A review of carvedilol arrhythmia data in clinical trials.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprolol; Carbazoles; Carvedilol; Death, Sudden, Cardiac; Digoxin; Heart Failure; Humans; Metoprolol; Myocardial Infarction; Propanolamines; Randomized Controlled Trials as Topic | 2005 |
New antiarrhythmic treatment of atrial fibrillation.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzofurans; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Carbazoles; Carvedilol; Cyclopropanes; Dronedarone; Fatty Acids, Omega-3; Furans; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Oligopeptides; Organic Chemicals; Peptidyl-Dipeptidase A; Potassium Channel Blockers; Propanolamines; Purinergic P1 Receptor Agonists | 2007 |
6 trial(s) available for carvedilol and amiodarone
Article | Year |
---|---|
Efficacy and safety of carvedilol in patients with chronic heart failure receiving concomitant amiodarone therapy. Australia/New Zealand Heart Failure Research Collaborative Group.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Carbazoles; Carvedilol; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Propanolamines; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Analysis; Treatment Outcome; Vasodilator Agents; Ventricular Function, Left | 1998 |
Dual chamber pacing in patients with severe heart failure on beta blocker and amiodarone treatment: preliminary results of a randomised study.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiac Pacing, Artificial; Carvedilol; Death, Sudden, Cardiac; Drug Therapy, Combination; Female; Heart Failure; Heart Transplantation; Humans; Male; Mitral Valve Insufficiency; Propanolamines; Stroke Volume | 2002 |
Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Carbazoles; Carvedilol; Electric Countershock; Female; Humans; Male; Middle Aged; Propanolamines; Prospective Studies; Secondary Prevention | 2004 |
Stereoselective effect of amiodarone on the pharmacokinetics of racemic carvedilol.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Carvedilol; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Female; Heart Failure; Humans; Male; Middle Aged; Propanolamines; Stereoisomerism | 2005 |
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprolol; Carbazoles; Carvedilol; Combined Modality Therapy; Defibrillators, Implantable; Female; Heart Arrest; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Propanolamines; Sotalol; Ventricular Fibrillation; Ventricular Function, Left | 2006 |
The safety of amiodarone in patients with heart failure.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Carbazoles; Carvedilol; Death, Sudden, Cardiac; Female; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Multivariate Analysis; Propanolamines | 2007 |
32 other study(ies) available for carvedilol and amiodarone
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.
Topics: Animals; Cattle; Cell Line; Cell Line, Tumor; Chagas Disease; Drug Evaluation, Preclinical; Hepatocytes; High-Throughput Screening Assays; Humans; Image Processing, Computer-Assisted; Muscle, Skeletal; Parasitic Sensitivity Tests; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Antiprion compounds that reduce PrP(Sc) levels in dividing and stationary-phase cells.
Topics: Animals; Blotting, Western; Cell Division; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Mice; Molecular Structure; PrPSc Proteins; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Impact of concurrent amiodarone treatment on the tolerability and efficacy of carvedilol in patients with chronic heart failure.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Carvedilol; Chi-Square Distribution; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Survival Rate; Ventricular Remodeling | 1999 |
Combination therapy with carvedilol and amiodarone in patients with severe heart failure.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Carvedilol; Drug Therapy, Combination; Electrocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pacemaker, Artificial; Prognosis; Propanolamines; Treatment Outcome | 2000 |
Impressive amelioration of clinical (NYHA class) and echocardiographic parameters in heart failure patients treated with amiodarone and carvedilol.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Carvedilol; Cytokines; Drug Therapy, Combination; Heart Failure; Humans; Propanolamines | 2001 |
[Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Atenolol; Baroreflex; Bisoprolol; Carbazoles; Carvedilol; Data Interpretation, Statistical; Death, Sudden, Cardiac; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Perindopril; Phenylephrine; Propanolamines; Time Factors; Ventricular Dysfunction, Left | 2004 |
Impact of a standardized titration protocol with carvedilol in heart failure: safety, tolerability, and efficacy-a report from the GESICA registry.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Argentina; Blood Pressure; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Patient Compliance; Predictive Value of Tests; Propanolamines; Prospective Studies; Stroke Volume; Systole; Titrimetry; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2005 |
Management of cardiovascular risk in patients receiving calcineurin inhibitors--a case report.
Topics: Acenocoumarol; Amiodarone; Angioplasty; Calcineurin Inhibitors; Carbazoles; Carvedilol; Cyclosporine; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Immunosuppressive Agents; Indoles; Kidney Transplantation; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Postoperative Complications; Pravastatin; Prednisone; Propanolamines; Risk Factors; Tacrolimus; Treatment Outcome | 2006 |
Simultaneous determination of ten antiarrhythic drugs and a metabolite in human plasma by liquid chromatography--tandem mass spectrometry.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Chromatography, Liquid; Diltiazem; Humans; Metoprolol; Mexiletine; Molecular Structure; Propanolamines; Propranolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry; Verapamil | 2007 |
Severe left ventricular dysfunction in infants with ventricular preexcitation.
Topics: Adrenergic alpha-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, Dilated; Cardiotonic Agents; Carvedilol; Diuretics; Female; Furosemide; Humans; Infant; Propanolamines; Risk Factors; Ventricular Dysfunction, Left; Ventricular Premature Complexes; Wolff-Parkinson-White Syndrome | 2008 |
Termination of recurrent ventricular tachycardia by continuous positive airway pressure ventilation.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, Hypertrophic; Carvedilol; Continuous Positive Airway Pressure; Defibrillators, Implantable; Heart Failure; Humans; Lung Diseases, Interstitial; Male; Propanolamines; Recurrence; Sleep Apnea Syndromes; Sotalol; Tachycardia, Ventricular | 2009 |
Combined amiodarone and low-dose carvedilol treatment for severe heart failure in childhood.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Furosemide; Heart Failure; Hemodynamics; Humans; Natriuretic Peptide, Brain; Propanolamines; Recurrence; Spironolactone; Vasodilator Agents; Ventricular Dysfunction, Left | 2010 |
Inhibitory and stimulative effects of amiodarone on metabolism of carvedilol in human liver microsomes.
Topics: Amiodarone; Carbazoles; Carvedilol; Drug Interactions; Humans; Isomerism; Metabolic Detoxication, Phase II; Microsomes, Liver; NADP; Oxidation-Reduction; Propanolamines; Uridine Diphosphate Glucuronic Acid | 2010 |
In-hospital monitoring of T-wave alternans in a case of amiodarone-induced torsade de pointes: clinical and methodologic insights.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bundle-Branch Block; Carbazoles; Carvedilol; Electrocardiography; Heart Failure; Humans; Hypertension, Pulmonary; Magnesium; Male; Propanolamines; Torsades de Pointes; Treatment Outcome; Ultrasonography | 2012 |
Chronotropic incompetence: real life observations of a theoretical concept.
Topics: Adrenergic beta-1 Receptor Antagonists; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Carvedilol; Exercise Test; Exercise Tolerance; Female; Heart Failure; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Vasodilator Agents | 2013 |
Docetaxel Induced Sclerosing Cholangitis.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Antineoplastic Agents; Carbazoles; Carvedilol; Cholangitis, Sclerosing; Docetaxel; Dronedarone; Drug Interactions; Humans; Leuprolide; Male; Nitriles; Propanolamines; Taxoids; Tosyl Compounds | 2015 |
In Vitro Enhancement of Carvedilol Glucuronidation by Amiodarone-Mediated Altered Protein Binding in Incubation Mixture of Human Liver Microsomes with Bovine Serum Albumin.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Carbazoles; Carvedilol; Female; Glucuronides; Humans; Male; Microsomes, Liver; Middle Aged; Propanolamines; Protein Binding; Serum Albumin | 2016 |
THE SAFETY AND EFFICACY OF AMIODARONE AND CARVEDILOL COMBINATION IN TREATMENT OF PATIENTS WITH SEVERE CARDIAC RHYTHM DISORDERS.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Carbazoles; Carvedilol; Drug Therapy, Combination; Heart Failure; Humans; Propanolamines; Retrospective Studies; Ventricular Dysfunction | 2017 |
Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Amiodarone; Animals; Carbazoles; Carvedilol; Cytochrome P-450 CYP2D6 Inhibitors; Dronedarone; Drug Interactions; Male; Models, Biological; Propanolamines; Rats, Sprague-Dawley; Substrate Specificity | 2018 |